Follow
A+ Science Holding AB
A+ Science is a complete clinical service CRO with long experience of services in clinical trials for pharmaceuticals (Phase I-IV) as well as medical devices. We also have experience in conducting non-interventional and registry trials. Our services are within clinical trial management, outsourcing of consultants and pharmacovigilance.
Sector:
HEALTH CARE
>
Pharmaceuticals
Status
This company has been delisted, therefore no further market information will be available.
News
Nothing to display for this company
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Type
Ticker
ISIN
Market
SHARE
ASCI
SE0001202029
Details of share in A+ Science Holding AB with ticker ASCI
Status
Delisted
Order book id
Amount of instruments
Par value
Market cap
Currency
SEK
Terms
Type
Price
Pre-money valuation
Time
Listing
-
-
10 Jun 2004
Direct listing of A+ Science Holding AB on Spotlight
Market
Spotlight
Status
Listed
Comment for Listing
Instrument details for the listing event: ISIN SE0001202029, ticker VNV
Type
Price
Pre-money valuation
Time
New issue
1.30 SEK
14.6M SEK
18 Jan - 05 Feb 2010
Share issue in A+ Science Holding AB
Former company name
Vita Nova Ventures AB
Market
Spotlight
Subscription period
18 Jan - 05 Feb 2010
Subscription price
1.30 SEK
Price per share
1.30 SEK
Target to raise
9 100 000 SEK
Types
Share issue
Pre-money valuation
14 600 000 SEK
Subscription block size
Minimum subscription
Record date
11 Jan 2010
Offer status
Closed
Listing status
Listed
Issue terms
Result of offer
Rights issue. Preference right 5:8. Shareholders in VNV receive one (1) subscription right for one (1) share they hold in VNV. For the acquisition of five (5) new shares in VNV, eight (8) subscription rights are required.
Comment for Offer
The company's largest owner, the Pomona Group, subscribes for its share of the shares and has also guaranteed the issue. Trading in subscription rights takes place January 18 - February 3, 2010.
Type
Price
Pre-money valuation
Time
New issue
1.00 SEK
18.2M SEK
05 May - 20 May 2011
Share issue in A+ Science Holding AB
Market
Spotlight
Subscription period
05 May - 20 May 2011
Subscription price
1.00 SEK
Price per share
1.00 SEK
Target to raise
15 200 000 SEK
Types
Share issue
Pre-money valuation
18 200 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Rights issue. Preference right 5:6. One (1) existing share gives one (1) subscription right. To subscribe for five (5) shares, six (6) subscription rights are required.
Comment for Offer
Trading in subscription rights will take place during the period 26 April to 11 May 2011. Update: The subscription period starts three days later than first planned, ie 29 April 2011. Update: The start of the subscription period is moved to 3 May 2011.
Type
Price
Pre-money valuation
Time
Delisting
-
-
29 Feb 2012
Delisting of A+ Science Holding AB from Spotlight
Market
Spotlight
Delisting date
29 Feb 2012
Instrument
ASCI with ISIN SE0001202029
Status
Delisted
Comment for Listing
Delisted from Spotlight (former Aktietorget) 2012, February 29.
People
Jennifer Heyno
CEO
Agneta Edberg
Chairman of the board
Johanna Andlin
Board member
Jennifer Heyno
Board member
Meg Tivéus
Board member
Company Details
Sector
HEALTH CARE

Address
Luntmakargatan 22
Zip code
11137
City/district
Stockholm
Country
Sweden (SE)
Registration number
556652-6835
LEI code
First trade date
10 Jun 2004
Company former names
Vita Nova Ventures AB
18 Jun 2010
Registration date
11 Dec 2003
Short name
A+ Science